𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Bioavailability of recombinant tumor necrosis factor determines its lethality in mice

✍ Scribed by Paul Ameloot; Nozomi Takahashi; Bart Everaerdt; Jeroen Hostens; Hans-Pietro Eugster; Walter Fiers; Peter Brouckaert

Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
105 KB
Volume
32
Category
Article
ISSN
0014-2980

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Combination tumor-immunotherapy with rec
Combination tumor-immunotherapy with recombinant tumor necrosis factor and recombinant interleukin 2 in mice
✍ Takashi Nishimura; So Ohta; Naoko Sato; Yuji Togashi; Makiko Goto; Yoshiyuki Has πŸ“‚ Article πŸ“… 1987 πŸ› John Wiley and Sons 🌐 French βš– 656 KB

Recombinant human tumor necrosis factor (r-TNF) inhibits growth of various mouse tumor cell lines both in vitro and in vivo. Treatment of established tumor nodules with intratumoral (i.t.) injection of r-TNF caused hemorrhagic necrosis of tumor and temporary disappearance of tumor mass. However, a s

Effect of recombinant human tumor necros
Effect of recombinant human tumor necrosis factor on tumor and spleen in mice
✍ E. Knippel; J. Rychly; H. A. Schulze; B. Ringel; A. Krygier-Stojalowska πŸ“‚ Article πŸ“… 1988 πŸ› John Wiley and Sons 🌐 French βš– 580 KB

The ability of recombinant human tumor necrosis factor (rH-TNF-alpha) to induce regression of sarcoma 180 in vivo was evaluated. The tumor was cured by TNF in the course of 4 weeks. TNF inhibited proliferation of sarcoma 180 cells in vitro, which suggests a direct effect of TNF on tumor cells in viv